Wilson Sonsini Goodrich & Rosati advised Motif Neurotech on the transaction. Neurotechnology company, Motif Neurotech announced it raised $18.75 million in oversubscribed Series A financing round. The...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Edgewise Therapeutics on the transaction, and Cooley represented the underwriters. Edgewise Therapeutics, Inc. (“Edgewise”) (NASDAQ: EWTX) announced the pricing of an underwritten...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Silo Technologies on the transaction. Silo Technologies announced the completition of a $35 million investment from Koch Disruptive Technologies (KDT). The...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Noctrix Health on the transaction. Noctrix Health Inc. announced it has closed a $40 million Series C financing round led...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Cleveland Diagnostics on the transaction. Cleveland Diagnostics, a clinical-stage biotechnology company developing next-generation diagnostic tests for the early detection of...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Arena BioWorks on patent and transactional matters. Arena BioWorks announced its launch as a biomedical research institute with a mission...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Alector in the offering, and Davis Polk & Wardwell represented the sole book-running manager and underwriter, Cantor Fitzgerald & Co....
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Ji Xing Pharmaceuticals Limited (JIXING) on the transaction. TMS Co., Ltd. (TMS) and Ji Xing Pharmaceuticals Limited (JIXING) announced that...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Cleva in the transaction. Nigerian fintech company Cleva, announced it has raised $1.5 million in pre-Seed funding. The round was led...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Hyperexponential in the transaction. Osborne Clarke advised Highland Europe. Hyperexponential announced the closing of its $73 million Series B funding round led...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Foresight Diagnostics on the transaction. Allogene Therapeutics Inc. (Nasdaq: ALLO) and Foresight Diagnostics, announced a strategic partnership to develop a minimal residual...
You must be a Standard 1 Year member to access this content.
Goodwin advised Renesas Electronics Corporation on the acquisition of Transphorm, assisted by Wilson Sonsini Goodrich & Rosati. On January 11, 2024, Renesas Electronics Corporation (Renesas, TSE:...
You must be a Standard 1 Year member to access this content.
